NSE:MARKSANS
Marksans Pharma Limited
- Stock
Last Close
167.15
26/04 10:00
Market Cap
65.05B
Beta: 1.23
Volume Today
2.11M
Avg: 2.09M
PE Ratio
22.85
PFCF: -
Dividend Yield
0.33%
Payout:0%
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 6.30B - | 7.97B 26.46% | 8.93B 12.13% | 7.67B 14.12% | 9.13B 18.97% | 9.87B 8.18% | 11.29B 14.38% | 13.68B 21.17% | 14.80B 8.17% | 18.52B 25.13% | |
cost of revenue | 3.68B - | 4.45B 21.07% | 5.10B 14.43% | 4.72B 7.39% | 5.48B 16.14% | 5.17B 5.60% | 5.68B 9.82% | 6.19B 8.84% | 7.48B 20.92% | 9.21B 23.17% | |
gross profit | 2.62B - | 3.51B 34.03% | 3.84B 9.22% | 2.95B 23.07% | 3.65B 23.50% | 4.70B 28.90% | 5.61B 19.40% | 7.50B 33.65% | 7.32B 2.36% | 9.31B 27.14% | |
selling and marketing expenses | 99.13M - | 236.78M 138.86% | 475.90M 100.98% | 666.31M 40.01% | 792.60M 18.95% | 1.10B 38.29% | 1.49B 36.35% | 1.03B 31.39% | |||
general and administrative expenses | 214.54M - | 192.03M 10.49% | 206.30M 7.43% | 232.05M 12.48% | 179.66M 22.58% | 238.83M 32.94% | 247.99M 3.84% | 162.62M 34.42% | |||
selling general and administrative expenses | 313.67M - | 428.82M 36.71% | 682.20M 59.09% | 898.35M 31.69% | 972.25M 8.23% | 1.33B 37.30% | 1.74B 30.53% | 2.52B 44.66% | |||
research and development expenses | 57.13M - | 83.15M 45.55% | 128.66M 54.74% | 192.50M 49.62% | 158.89M 17.46% | ||||||
other expenses | 1.60B - | 1.83B 14.16% | 2.48B 35.80% | 2.50B 0.75% | 1.99M 99.92% | 903.63K 54.65% | 1.50M 66.24% | 38.73M 2,478.44% | 95.62M 146.87% | 593.13M 520.30% | |
cost and expenses | 5.28B - | 6.28B 18.97% | 7.89B 25.64% | 7.65B 3.08% | 8.61B 12.60% | 8.78B 1.96% | 9.64B 9.75% | 10.50B 8.93% | 12.63B 20.36% | 15.65B 23.85% | |
operating expenses | 1.60B - | 1.83B 14.16% | 2.79B 52.98% | 2.93B 4.79% | 3.13B 6.90% | 3.61B 15.21% | 3.95B 9.65% | 4.31B 9.05% | 5.15B 19.56% | 6.43B 24.82% | |
interest expense | 86.98M - | 62.94M 27.64% | 39.61M 37.07% | 64.94M 63.93% | 59.25M 8.76% | 49.70M 16.11% | 34.68M 30.23% | 53.90M 55.44% | 91.28M 69.35% | ||
ebitda | 1.18B - | 1.81B 53.39% | 1.41B 21.83% | 495.59M 64.92% | 831.35M 67.75% | 1.33B 59.76% | 1.89B 42.18% | 3.54B 87.69% | 2.95B 16.88% | 3.99B 35.33% | |
operating income | 864.11M - | 1.56B 80.40% | 1.07B 31.46% | 155.29M 85.47% | 515.99M 232.27% | 1.09B 111.89% | 1.70B 55.70% | 3.09B 81.64% | 2.14B 30.76% | 2.88B 34.39% | |
depreciation and amortization | 156.91M - | 161.34M 2.82% | 281.27M 74.33% | 300.93M 6.99% | 268.38M 10.82% | 228.04M 15.03% | 266.62M 16.92% | 361.51M 35.59% | 447.76M 23.86% | 518.53M 15.81% | |
total other income expenses net | -157.09M - | -127.69M 18.72% | 25.56M 120.02% | 131.04M 412.71% | -18.01M 113.74% | -50.28M 179.23% | -130.67M 159.87% | -70.56M 46.00% | 334.07M 573.46% | 499.21M 49.43% | |
income before tax | 864.11M - | 1.56B 80.40% | 1.07B 31.46% | 155.29M 85.47% | 497.98M 220.67% | 1.04B 109.46% | 1.57B 50.68% | 3.02B 92.25% | 2.48B 18.09% | 3.38B 36.42% | |
income tax expense | 127.87M - | 439.21M 243.48% | 241.08M 45.11% | 35.15M 85.42% | 139.97M 298.22% | 238.69M 70.53% | 364.19M 52.58% | 636.25M 74.70% | 606.97M 4.60% | 723.32M 19.17% | |
net income | 719.08M - | 1.09B 52.13% | 785.12M 28.23% | 95.19M 87.88% | 329.40M 246.05% | 804.37M 144.19% | 1.21B 50.12% | 2.39B 97.54% | 1.85B 22.62% | 2.66B 44.29% | |
weighted average shs out | 385.31M - | 409.31M 6.23% | 409.31M 0% | 409.31M 0% | 409.31M 0% | 409.31M 0% | 409.31M 0% | 409.31M 0.00% | 409.31M 0% | 415.40M 1.49% | |
weighted average shs out dil | 385.31M - | 409.31M 6.23% | 409.31M 0% | 409.31M 0% | 409.31M 0% | 409.31M 0% | 409.31M 0% | 409.31M 0.00% | 409.31M 0% | 415.40M 1.49% | |
eps | 1.87 - | 2.67 42.78% | 1.92 28.09% | 0.22 88.54% | 0.80 263.64% | 1.97 146.25% | 2.86 45.18% | 5.76 101.40% | 4.51 21.70% | 6.41 42.13% | |
epsdiluted | 1.87 - | 2.67 42.78% | 1.92 28.09% | 0.22 88.54% | 0.80 263.64% | 1.97 146.25% | 2.86 45.18% | 5.76 101.40% | 4.51 21.70% | 6.41 42.13% |
All numbers in INR (except ratios and percentages)